Advertisement
Advertisement

ETON

ETON logo

Eton Pharmaceuticals Inc

12.63
USD
-0.01
-0.08%
Dec 18, 14:00 UTC -5
Open

Eton Pharmaceuticals Inc Profile

About

Eton Pharmaceuticals Inc. operates as a development stage biotechnology company. Its product pipeline consists of DS-300, EM-100, DS-100, DS-200, ET-103, ET-101, ET-102 and CT-100 which are in clinical stage. Eton Pharmaceuticals Inc. is based in Deer Park, Illinois.

Info & Links

CEO

Sean E. Brynjelsen

Headquarters

21925 W. FIELD PARKWAY, SUITE 235
DEER PARK, IL 60010, UNITED STATES

Auditor

KMJ Corbin & Company LLP

Share holders

6

Employees

30

Eton Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization2

326.36M

Enterprise Value

310.22M

Enterprise Value/EBITDA(ttm)

-77.44

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

9.20

Price to Book(mrq)

19.97

Price to Cash(ytd)

3.86K

Profitability

Gross Margin(ttm)

58.88%

Operating Margin(ttm)

-15.81%

Profit Margin(ttm)

-17.12%

Return on Equity(ttm)

-36.29%

Return on Invested Capital(ttm)

-38.48%

Return on Assets(ttm)

-16.84%

Income Statement

Revenue(ttm)

34.68M

Revenue Per Share(ttm)

1.34

Gross Profit(ttm)

20.57M

EBITDA(ttm)3

-4.01M

Net Income Available to Common(ttm)

-5.48M

Diluted EPS(ttm)

-0.22

Share Statistics

Beta (5Y Monthly)

1.39

52-Week Change

245.08%

S&P 500 52-Week Change

27.82%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

25.84M

Dividend Yield

0.00%

Float4

22.17M

% Held by Insiders

14.89%

% Held by Institutions

27.86%

Balance Sheet

Total Cash(mrq)

20.26M

Total Cash Per Share(mrq)

0.78

Total Debt(mrq)

4.13M

Total Debt/Equity(mrq)

25.81%

Current Ratio(mrq)

1.51%

Quick Ratio(mrq)

1.41%

Book Value Per Share(mrq)

0.62

Cash Flow

Operating Cash Flow Per Share(ytd)

0.07

Free Cash Flow(ytd)

1.72M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement